Is RPTX or RYLD a better dividend investment in 2026?

RPTX currently yields 75.47% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: RPTX offers higher current income.

What is the dividend yield difference between RPTX and RYLD?

RPTX has a forward dividend yield of 75.47% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 63.33 percentage points.

Home › Compare › RPTX vs RYLD

RPTX vs RYLD: Dividend Comparison 2026

RPTX yields 75.47% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RPTX wins by $1.31M in total portfolio value

INVESTMENT

TIME HORIZON10 years

RPTX

● Live price

75.47%

Share price

$2.65

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.35M

Annual income

$375,142.22

Full RPTX calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — RPTX vs RYLD

📍 RPTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RPTX	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RPTX + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RPTX pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RPTX

Annual income on $10K today (after 15% tax)

$6,415.09/yr

After 10yr DRIP, annual income (after tax)

$318,870.89/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, RPTX beats the other by $316,671.64/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RPTX + RYLD for your $10,000?

RPTX: 50%RYLD: 50%

100% RYLD50/50100% RPTX

Portfolio after 10yr

$698.7K

Annual income

$188,864.78/yr

Blended yield

27.03%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on RPTX right now

RPTX

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$3.00

+13.2% upside vs current

Range: $3.00 — $3.00

Altman Z

-0.1

Piotroski

3/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RPTX buys

RYLD buys

No recent congressional trades found for RPTX or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRPTXRYLD

Forward yield	75.47% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$1.35M	$44.5K ✓
Annual income after 10y	$375,142.22 ✓	$2,587.35
Total dividends collected	$1.17M	$18.8K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: RPTX vs RYLD ($10,000, DRIP)

Year	RPTX Portfolio	RPTX Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$18,247	$7,547.17	$11,914	$1,213.65	+$6.3K → RPTX
2	$32,395	$12,870.51	$14,099	$1,351.30	+$18.3K → RPTX
3	$56,017	$21,354.74	$16,580	$1,494.55	+$39.4K → RPTX
4	$94,449	$34,510.84	$19,384	$1,642.61	+$75.1K → RPTX
5	$155,442	$54,381.15	$22,535	$1,794.70	+$132.9K → RPTX
6	$249,967	$83,643.80	$26,063	$1,950.00	+$223.9K → RPTX
7	$393,173	$125,708.24	$29,995	$2,107.69	+$363.2K → RPTX
8	$605,486	$184,791.09	$34,361	$2,266.99	+$571.1K → RPTX
9	$913,831	$265,960.98	$39,194	$2,427.12	+$874.6K → RPTX
10	$1,352,941	$375,142.22	$44,525	$2,587.35	+$1.31M → RPTX

RPTX vs RYLD: Complete Analysis 2026

RPTX — Stock

Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing RP-6306, which is under Phase I clinical trial for tumors with genetic alterations characterized by CCNE1 amplification; and Polymerase Theta program, a SL target associated with BRCA mutations and other genomic alterations. The company was incorporated in 2016 and is headquartered in Montreal, Canada.

Full RPTX Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this RPTX vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RPTX vs SCHD RPTX vs JEPI RPTX vs O RPTX vs KO RPTX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.